GIT1 and breast carcinoma: From a breast cancer diagnostics perspective, it is interesting to note that the GIT1 protein levels were lower in ER(−) than in ER(+) breast cancer and that lower GIT1 levels in ER(−) breast cancer patients correlated with poor relapse-free survival.